Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-25 9:18 pm Sale | 2025-02-21 | 13D | Singular Genomics Systems, Inc. OMIC | James E. Flynn | 1,000 100.000% | -248,495 (-99.60%) | Filing History |
| 2025-01-16 2:52 pm Sale | 2024-12-31 | 13G | Singular Genomics Systems, Inc. OMIC | Domain Partners IX, L.P. | 125,466 4.950% | -0 (-0.00%) | Filing History |
| 2024-12-26 8:55 pm Unchanged | 2024-12-22 | 13D | Singular Genomics Systems, Inc. OMIC | James E. Flynn | 249,495 6.620% | 0 (Unchanged) | Filing History |
| 2024-11-22 7:55 pm Sale | 2024-11-20 | 13D | Singular Genomics Systems, Inc. OMIC | CRCM LP | 115,849 4.610% | -25,125 (-17.82%) | Filing History |
| 2024-11-05 7:29 pm Purchase | 2024-10-30 | 13D | Singular Genomics Systems, Inc. OMIC | CRCM LP | 140,974 5.600% | 140,974 (New Position) | Filing History |
| 2024-11-01 7:54 pm Unchanged | 2024-10-31 | 13D | Singular Genomics Systems, Inc. OMIC | James E. Flynn | 249,495 6.660% | 0 (Unchanged) | Filing History |
| 2024-09-18 4:26 pm Purchase | 2024-09-16 | 13D | Singular Genomics Systems, Inc. OMIC | TANG CAPITAL MANAGEMENT, LLC | 372,000 14.900% | 372,000 (New Position) | Filing History |
| 2024-09-12 4:07 pm Purchase | 2024-09-05 | 13D | Singular Genomics Systems, Inc. OMIC | James E. Flynn | 249,495 6.660% | 249,495 (New Position) | Filing History |
| 2024-02-14 4:16 pm Purchase | 2023-12-31 | 13G | Singular Genomics Systems, Inc. OMIC | Glezer Eli N. | 162,403 6.600% | 19,083 (+13.32%) | Filing History |
| 2024-02-14 4:15 pm Purchase | 2023-12-31 | 13G | Singular Genomics Systems, Inc. OMIC | Spaventa Andrew | 198,603 7.900% | 36,160 (+22.26%) | Filing History |
| 2024-02-12 5:31 pm Sale | 2023-12-31 | 13G | Singular Genomics Systems, Inc. OMIC | James E. Flynn | 250,496 6.830% | -13,393 (-5.08%) | Filing History |
| 2024-01-25 4:23 pm Sale | 2023-12-31 | 13G | Singular Genomics Systems, Inc. OMIC | Domain Partners IX, L.P. | 125,466 5.100% | -21,055 (-14.37%) | Filing History |
| 2023-08-14 5:07 pm Sale | 2023-08-09 | 13G | Singular Genomics Systems, Inc. OMIC | James E. Flynn | 263,889 7.400% | -35,474 (-11.85%) | Filing History |
| 2023-02-14 5:08 pm Purchase | 2022-12-31 | 13G | Singular Genomics Systems, Inc. OMIC | Glezer Eli N. | 143,319 6.000% | 5,486 (+3.98%) | Filing History |
| 2023-02-14 4:30 pm Purchase | 2022-12-31 | 13G | Singular Genomics Systems, Inc. OMIC | Spaventa Andrew | 162,444 6.700% | 8,151 (+5.28%) | Filing History |
| 2023-02-14 07:43 am Sale | 2022-12-31 | 13G | Singular Genomics Systems, Inc. OMIC | Revelation Alpine LLC | 39,483 1.700% | -126,804 (-76.26%) | Filing History |
| 2023-02-10 2:29 pm Sale | 2022-12-31 | 13G | Singular Genomics Systems, Inc. OMIC | James E. Flynn | 299,362 9.070% | -5,372 (-1.76%) | Filing History |
| 2022-02-14 4:32 pm Purchase | 2021-12-31 | 13G | Singular Genomics Systems, Inc. OMIC | Spaventa Andrew | 154,292 6.400% | 154,292 (New Position) | Filing History |
| 2022-02-14 4:30 pm Purchase | 2021-12-31 | 13G | Singular Genomics Systems, Inc. OMIC | Glezer Eli N. | 137,833 5.700% | 137,833 (New Position) | Filing History |
| 2022-02-14 09:28 am Purchase | 2021-12-31 | 13G | Singular Genomics Systems, Inc. OMIC | Revelation Alpine LLC | 166,287 6.900% | 166,287 (New Position) | Filing History |